FOLH1 and prostate cancer: Furthermore, Yi, N. et al. used SUVmax, as it was calculated in the 68Ga-PSMA PET/CT images of 147 patients with localized prostate cancer, to prove that it was a predicting factor of intermediate and high-risk prostate cancer.